AbbVie Inc (ABBV) earnings · P/E 81, rev $16.99B
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
This ABBV earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ABBV revenue for 2026-06-30 was $16.99B. Net income was $3.61B. Revenue was up 13.3% from 2026-03-31 to 2026-06-30. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
When the next ABBV 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 13.3% from 2026-03-31 to 2026-06-30. An earnings headline that ignores that move is noise.
Not investment advice. Full ABBV research stays on the stock page; the tape stays on the quote page.
Not investment advice.